abstract |
The present invention relates to pharmaceutical compositions for topical application comprising a safe and effective amount of a pharmaceutical active, from about 0.1% to about 10.0% of a high molecular weight cationic polymer, from about 0.05% to about 5% of a high HLB non-ionic surfactant, and from about 0.1% to about 25% of an alkoxylated ether. In further embodiments, these compositions also comprise from about 0.01% to about 5% of a low HLB non-ionic surfactant. |